TreatmentDescriptionAdvantagesDisadvantages
GnRH therapyMedical therapy to suppress estrogen production and shrink uterine fibroidsShrinkage of uterine fibroids may allow removal with less blood loss, or removal by laparoscope or hysteroscopeInduces premature menopause-like symptoms; associated with premature bone mineral loss3; rapid regrowth of fibroids when therapy is discontinued
Abdominal myomectomyOpen abdominal surgery to resect symptomatic uterine fibroidsAllows uterine conservation, usually in women who desire fertilityPostoperative recovery period of six weeks; general anesthesia required; transfusion rate of 3 to 20 percent3,4; adhesions may cause problems5; recurrence rate of 10 to 27 percent5,6
Laparoscopic myomectomyLaparoscopic removal of uterine fibroidsMuch shorter recovery period than with abdominal myomectomy; best suited for pedunculated and subserosal fibroids or smaller intramural fibroids7,8 Large, multiple or deep uterine fibroids are problematic; procedure-related adhesion formation may be significant; general anesthesia required7,8
Laparoscopic myolysisLaser probe used to heat coagulate uterine fibroidsTreated uterine fibroids may shrink up to 40 percent by 6-month follow-up7 “Dense and fibrous adhesions” noted at second-look laparoscopy7*
Hysteroscopic resection and/or endometrial ablationHysteroscope is inserted into endometrial cavity, guiding the resection of submucous fibroids; endometrium is scraped and burned to create amenorrheaOutpatient procedure for bleeding patients; short recovery periodMortality from fluid overload and infection reported but rare; a 32 percent failure rate reported at 2 years post-ablation9 with a high rate (52 percent) of adenomyosis, possibly caused by ablation10; destroys fertility potential; a 13 percent rate of synechiae formation following hysteroscopic resection without ablation10
Uterine fibroid embolizationAn arteriographic catheter is passed through the femoral artery into the uterine arteries; tiny particles are injected that block blood flow inside the fibroids and cause infarct; other uterine structures are spared; uterine fibroids shrink, relieving symptomsAbnormal bleeding and “bulk symptoms” improved in about 80 to 90 percent of patients11,12; surgical incision and general anesthesia not required; no blood loss; all fibroids treated at once13; no recurrences noted14 ; return to normal activities in 7 to 10 daysAs expensive as hysterectomy; effect on fertility uncertain; delayed infection may occur in a small percentage of patients; availability to all patients may be limited; long-term follow-up data unavailable; some HMOs may not cover procedure cost